Circulating preptin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects

Annals of Medicine

Volumn 41, Issue 1, 2009, Pages 52-56

  Yang, Gangyi ^a   Li, Ling ^a   Chen, Wenwen ^a   Liu, Hua ^b   Boden, Guenther ^c   Li, Ke ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Metabolism; Physiological amplifier; Preptin; T2DM

Indexed keywords

FATTY ACID; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PEPTIDE HORMONE; PROTEIN PREPTIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ANTHROPOMETRY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HORMONE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BLOOD PRESSURE; CHINA; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FATTY ACIDS; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; SEX FACTORS; TRIGLYCERIDES;

EID: 60549116335     PISSN: 07853890     EISSN: 16512219     Source Type: Journal    
DOI: 10.1080/07853890802244142     Document Type: Article

References (13)

1. Cooper G, Willis A, Clark A, Turner R, Sim R, Reid K. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A. 1987;84:8628-32.
2. Tatemoto K, Efendic S, Mutt V, Makk G, Feitner G, Barachas J. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature (London). 1986;324:476-8.
3. Hutton J, Hansen F, Peshavaria M. Beta-Granins: 21 kDa co-secreted peptides of the insulin granule closely related to adrenal medullary chromogranin A. FEBS Lett. 1985;188:336-40.
4. Cooper G. Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease. Endocr Rev. 1994;15:163-201.
5. Hettiarachchi M, Chalkley S, Furler M, Choong Y, Heller M, Cooper G, et al. Rat amylin-(8-37) enhances insulin action and alters lipid metabolism in normal and insulin-resistant rats. Am J Physiol. 1997;273:E859-67.
6. Sanchez-Margalet V, Lucas M, Goberna R. Pancreastatin: further evidence for its consideration as a regulatory peptide. J Mol Endocrinol. 1996;16:1-8.
7. Cornish J, Callon KE, Bava U, Watson M, Xu X, Lin JM et al.. Preptin, another peptide product of the pancreatic β-cell, is osteogenic in vitro and in vivo. Am J Physiol Endocrinol Metab. 2007;292:E117-22.
8. Buchanan CM, Phillips ARJ, Cooper GJS. Preptin derived from proinsulin-like growth factor II (proIGF-II) is secreted from pancreatic islet β-cells and enhances insulin secretion. Biochem J. 2001;360:431-9.
9. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. 1. Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med. 1998;15:539-53.
10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
11. Kahn CR. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes. 1994;43:1066-84.
12. Taylor SI. Insulin resistance or insulin deficiency: which is the primary cause of NIDDM? Diabetes. 1994;43:735-40.
13. Reid IR. Relationships among body mass, its components, and bone. Bone. 2002;31:547-55.